# John K. Chan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-k-chan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,208 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 75 |
| i10-index | 196 |
| Last Known Institution | Sutter Health |
| OpenAlex ID | https://openalex.org/A5024129361 |
| ORCID iD | https://orcid.org/0000-0003-3379-6829 |
| Works | 596 |

## Researcher papers

- [Inherited Mutations in Women With Ovarian Carcinoma](https://scholariq.org/papers/inherited-mutations-in-women-with-ovarian-carcinoma/)
- [Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial](https://scholariq.org/papers/bevacizumab-and-paclitaxel-carboplatin-chemotherapy-and-secondary-cytoreduction/)
- [Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial](https://scholariq.org/papers/niraparib-monotherapy-for-late-line-treatment-of-ovarian-cancer-quadra-a/)
- [Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer](https://scholariq.org/papers/final-overall-survival-of-a-randomized-trial-of-bevacizumab-for-primary/)
- [Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer](https://scholariq.org/papers/weekly-vs-every-3-week-paclitaxel-and-carboplatin-for-ovarian-cancer/)
- [Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types](https://scholariq.org/papers/analysis-of-heritability-and-shared-heritability-based-on-genome-wide/)
- [Uterine Neoplasms, Version 1.2014](https://scholariq.org/papers/uterine-neoplasms-version-1-2014/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments-2/)

## Researcher university

- [Sutter Health](https://scholariq.org/institutions/sutter-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.